Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting.

Autor: Ciolli G; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Piccini M; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Mannelli F; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Gianfaldoni G; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Scappini B; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Fasano L; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Crupi F; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Quinti E; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Pasquini A; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Caroprese J; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Rotunno G; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Pancani F; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Signori L; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Maccari C; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Vanderwert FI; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Guglielmelli P; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Vannucchi AM; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence. amvannucchi@unifi.it.

Publikováno v: Haematologica [Haematologica] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.